Trials / Completed
CompletedNCT00519025
Risk Factors for Linezolid Resistance in Staphylococcus Aureus
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 360 (actual)
- Sponsor
- University of Pittsburgh · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is a retrospective chart review study. The proposed study aims to document the risk factors for quinolone resistance in bloodstream isolates of Klebsiella species. Additionally, the adequacy of empiric antibiotic therapy for Klebsiella bloodstream infections will be assessed.
Detailed description
This is a retrospective chart review study. The proposed study aims to document the risk factors for quinolone resistance in bloodstream isolates of Klebsiella species. Additionally, the adequacy of empiric antibiotic therapy for Klebsiella bloodstream infections will be assessed. This research is important because identification of risk factors may allow earlier initiation of appropriate therapy in patients infected with these bacteria. Additionally, we will identify whether horizontal spread is responsible for this increasing trend.
Conditions
Timeline
- Start date
- 2007-08-01
- Primary completion
- 2017-06-01
- Completion
- 2017-06-01
- First posted
- 2007-08-21
- Last updated
- 2018-06-12
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00519025. Inclusion in this directory is not an endorsement.